Daniel Bensen - Mar 21, 2023 Form 4 Insider Report for Tyra Biosciences, Inc. (TYRA)

Role
Chief Operating Officer
Signature
/s/ Ali D. Fawaz, Attorney-in-Fact
Stock symbol
TYRA
Transactions as of
Mar 21, 2023
Transactions value $
-$349,769
Form type
4
Date filed
3/23/2023, 07:47 PM
Previous filing
Sep 8, 2022
Next filing
Mar 29, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TYRA Common Stock Options Exercise $8.6K +14.1K +2.67% $0.61* 542K Mar 21, 2023 Direct
transaction TYRA Common Stock Sale -$226K -14.1K -2.6% $16.00 528K Mar 21, 2023 Direct F1
transaction TYRA Common Stock Options Exercise $2.32K +3.8K +0.72% $0.61* 532K Mar 22, 2023 Direct
transaction TYRA Common Stock Sale -$60.8K -3.8K -0.71% $16.00 528K Mar 22, 2023 Direct F1
transaction TYRA Common Stock Options Exercise $2.94K +4.83K +0.91% $0.61* 533K Mar 23, 2023 Direct
transaction TYRA Common Stock Sale -$77.2K -4.83K -0.91% $16.00 528K Mar 23, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TYRA Stock Option (Right to Buy) Options Exercise $0 -14.1K -5.22% $0.00 256K Mar 21, 2023 Common Stock 14.1K $0.61 Direct F2
transaction TYRA Stock Option (Right to Buy) Options Exercise $0 -3.8K -1.48% $0.00 252K Mar 22, 2023 Common Stock 3.8K $0.61 Direct F2
transaction TYRA Stock Option (Right to Buy) Options Exercise $0 -4.83K -1.91% $0.00 247K Mar 23, 2023 Common Stock 4.83K $0.61 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in March 2022.
F2 25% of the shares subject to the option vested on January 27, 2021, and 1/48th of the shares subject to the option vest monthly thereafter.